Intensity Therapeutics, Inc.INTSNASDAQ
Loading
PB Ratio: Premium ValuationElevated
Percentile Rank100
5Y CAGR+26.1%
Year-over-Year Change

Price-to-book ratio

5Y CAGR
+26.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
3.2x
Strong expansion
Streak
4 yr
Consecutive growthElevated
PeriodValueYoY Change
20248.39+68.3%
20234.98+470.2%
2022-1.35+42.5%
2021-2.34+82.1%
2020-13.04-595.1%
20192.63-